Gene · 5428
Papers4,408
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,408
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenomics and the Management of Mood Disorders-A Review. | J Pers Med | 2023 | 37511796 | PubTator, text mining | PubMed |
| Genomic Instability Evolutionary Footprints on Human Health: Driving Forces or Side Effects? | Int J Mol Sci | 2023 | 37511197 | PubTator, text mining | PubMed |
| Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease. | Antioxidants (Basel) | 2023 | 37507899 | PubTator, text mining | PubMed |
| A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes. | Curr Issues Mol Biol | 2023 | 37504295 | PubTator, text mining | PubMed |
| Inclusion body myositis with early onset: a population-based study. | J Neurol | 2023 | 37498322 | PubTator, text mining | PubMed |
| Exosomal lncRNA LINC01268 promotes pancreatic cancer progression via the miR-217-KIF2A-PI3K/AKT axis. | Genes Dis | 2023 | 37492701 | PubTator, text mining | PubMed |
| Multidisciplinary molecular consultation increases the diagnosis of pediatric epileptic encephalopathy and neurodevelopmental disorders. | Mol Genet Genomic Med | 2023 | 37489029 | PubTator, text mining | PubMed |
| The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy. | Front Neurol | 2023 | 37483446 | PubTator, text mining | PubMed |
| Broadening the Spectrum of SLC22A5 Phenotype: Primary Carnitine Deficiency Presenting with Focal Myoclonus. | Child Neurol Open | 2023 | 37475835 | PubTator, text mining | PubMed |
| Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy. | JAMA Netw Open | 2023 | 37471090 | PubTator, text mining | PubMed |
| The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders. | IUBMB Life | 2023 | 37470284 | PubTator, text mining | PubMed |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. | J Ovarian Res | 2023 | 37460928 | PubTator, text mining | PubMed |
| Treatment of pediatric convulsive status epilepticus. | Front Neurol | 2023 | 37456627 | PubTator, text mining | PubMed |
| Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics. | Hum Genomics | 2023 | 37452347 | PubTator, text mining | PubMed |
| Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis. | Cancer Cell Int | 2023 | 37452331 | PubTator, text mining | PubMed |
| Mitochondrial encephalopathy with lactic-acidosis and stroke-like episodes syndrome presenting as progressive supranuclear palsy. | Parkinsonism Relat Disord | 2023 | 37451107 | PubTator, text mining | PubMed |
| Bypass of Abasic Site-Peptide Cross-Links by Human Repair and Translesion DNA Polymerases. | Int J Mol Sci | 2023 | 37446048 | PubTator, text mining | PubMed |
| Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae. | Int J Mol Sci | 2023 | 37445873 | PubTator, text mining | PubMed |
| Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions. | Int J Mol Sci | 2023 | 37445598 | PubTator, text mining | PubMed |
| Hypomyelination caused by a novel homozygous pathogenic variant in FOLR1: complete clinical and radiological recovery with oral folinic acid therapy and review of the literature. | Orphanet J Rare Dis | 2023 | 37443037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5428/papers?page=17